NasdaqCM - Delayed Quote USD
Ainos, Inc. (AIMDW)
At close: October 17 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
65.1220
122.1120
3,519.6270
594.5630
16.5630
--
Cost of Revenue
271.3070
375.8450
2,114.2840
184.1810
11.2770
--
Gross Profit
-206.1850
-253.7330
1,405.3430
410.3820
5.2860
--
Operating Expense
14,339.6810
12,952.6630
15,381.5550
4,277.8080
1,445.7210
--
Operating Income
-14,545.8660
-13,206.3960
-13,976.2120
-3,867.4260
-1,440.4350
--
Net Non Operating Interest Income Expense
-262.0630
-144.1930
-53.5280
-18.6890
-10.1850
--
Other Income Expense
-601.4500
-419.1600
23.0500
-2.5470
-0.0030
--
Pretax Income
-15,409.3790
-13,769.7490
-14,006.6900
-3,888.6620
-1,450.6230
--
Tax Provision
0.8000
0.8000
--
--
--
--
Net Income Common Stockholders
-15,410.1790
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
--
Diluted NI Available to Com Stockholders
-15,410.1790
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
--
Total Operating Income as Reported
-14,545.8660
-13,206.3960
-13,976.2120
-3,867.4260
-1,440.4350
--
Total Expenses
14,610.9880
13,328.5080
17,495.8390
4,461.9890
1,456.9980
--
Net Income from Continuing & Discontinued Operation
-15,410.1790
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
--
Normalized Income
-15,410.1790
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
--
Interest Expense
262.0630
144.1930
53.5280
18.6890
10.1850
--
Net Interest Income
-262.0630
-144.1930
-53.5280
-18.6890
-10.1850
--
EBIT
-15,147.3160
-13,625.5560
-13,953.1620
-3,869.9730
-1,440.4380
--
EBITDA
-10,300.8370
-8,754.4990
-9,119.7340
-1,825.5260
-1,425.7400
--
Reconciled Cost of Revenue
271.3070
375.8450
2,114.2840
184.1810
11.2770
--
Reconciled Depreciation
4,846.4790
4,871.0570
4,833.4280
2,044.4470
14.6980
--
Net Income from Continuing Operation Net Minority Interest
-15,410.1790
-13,770.5490
-14,006.6900
-3,888.6610
-1,450.6230
--
Normalized EBITDA
-10,300.8370
-8,754.4990
-9,119.7340
-1,825.5260
-1,425.7400
--
Tax Rate for Calcs
0.0002
--
--
--
--
--
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TNONW Tenon Medical, Inc.
0.0245
-14.93%
PMEDF Predictmedix AI Inc.
0.0200
0.00%
NXLIW Nexalin Technology, Inc.
0.3001
-7.66%
BBLGW Bone Biologics Corporation
30.00
+3.45%
PMED.CN Predictmedix AI Inc.
0.0250
0.00%
TLT.V Theralase Technologies Inc.
0.2900
-17.14%
INBS Intelligent Bio Solutions Inc.
1.5600
+8.33%
TELA TELA Bio, Inc.
2.8600
+10.85%
ICAD iCAD, Inc.
1.9600
+4.81%
ICCM IceCure Medical Ltd
0.6200
+12.73%